sri 63-441 has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenbaum, JT; Rubin, RM | 1 |
| Banner, B; Chapchap, P; Esquivel, CO; Makowka, L; Mazzaferro, V; Miller, C; Pan, C; Podesta, L; Pressley, D; Todo, S | 1 |
2 other study(ies) available for sri 63-441 and Innate Inflammatory Response
| Article | Year |
|---|---|
A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation.
Topics: Animals; Aqueous Humor; Capillary Permeability; Dinoprostone; Eye; Female; Flurbiprofen; Inflammation; Interleukin-1; Leukocyte Count; Platelet Activating Factor; Prednisolone; Prostaglandins E; Proteins; Quinolinium Compounds; Rabbits; Recombinant Proteins | 1988 |
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.
Topics: Alprostadil; Animals; Biopsy; Dogs; Epoprostenol; Female; Graft Survival; Inflammation; Kidney; Kidney Transplantation; Male; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Renal Circulation; Swine; Transplantation, Heterologous | 1987 |